Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J.

J Diabetes Res. 2019 Nov 11;2019:2018374. doi: 10.1155/2019/2018374. eCollection 2019.

2.

[Patients' competences and health literacy assessment questionnaire].

Navarro Rubio MD, Gálvez P, Vázquez J; en representación del Grupo de Trabajo VACS; Componentes del Grupo de Trabajo VACS.

J Healthc Qual Res. 2019 Jul - Aug;34(4):193-200. doi: 10.1016/j.jhqr.2019.04.005. Epub 2019 Jul 26. Spanish.

PMID:
31713530
3.

Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.

Mata-Cases M, Franch-Nadal J, Real J, Cedenilla M, Mauricio D.

BMJ Open. 2019 Oct 28;9(10):e031281. doi: 10.1136/bmjopen-2019-031281.

4.

Assessment of Inner Retinal Layers and Choroidal Thickness in Type 1 Diabetes Mellitus: A Cross-Sectional Study.

Carbonell M, Alonso N, Castelblanco E, Real J, Ramírez-Morros A, Simó R, Hernández C, Jurjo C, Traveset A, Valldeperas X, Mauricio D.

J Clin Med. 2019 Sep 8;8(9). pii: E1412. doi: 10.3390/jcm8091412.

5.

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D.

J Clin Med. 2019 Sep 5;8(9). pii: E1389. doi: 10.3390/jcm8091389.

6.

Design and Validation of an Instrument To Measure a Minor's Maturity When Faced with Health Decisions.

Miquel E, Esquerda M, Real J, Espejo M, Pifarré J.

J Bioeth Inq. 2019 Sep;16(3):431-441. doi: 10.1007/s11673-019-09930-4. Epub 2019 Aug 1.

7.

Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D.

Curr Med Res Opin. 2019 Oct;35(10):1735-1744. doi: 10.1080/03007995.2019.1618806. Epub 2019 Jun 17.

PMID:
31081693
8.

Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.

Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacòs M, Mauricio D.

Diabetes Obes Metab. 2019 Jun;21(6):1373-1380. doi: 10.1111/dom.13663. Epub 2019 Mar 19.

PMID:
30756446
9.

Type 1 Diabetic Subjects with Diabetic Retinopathy Show an Unfavorable Pattern of Fat Intake.

Granado-Casas M, Ramírez-Morros A, Martín M, Real J, Alonso N, Valldeperas X, Traveset A, Rubinat E, Alcubierre N, Hernández M, Puig-Domingo M, Lecube A, Castelblanco E, Mauricio D.

Nutrients. 2018 Aug 29;10(9). pii: E1184. doi: 10.3390/nu10091184.

10.

Confidence interval reporting for measures of association in multivariable regression models in observational studies.

González-Marrón A, Real J, Forné C, Roso-Llorach A, Navarrete-Muñoz EM, Martínez-Sánchez JM.

Med Clin (Barc). 2019 Sep 27;153(6):239-242. doi: 10.1016/j.medcli.2018.06.018. Epub 2018 Aug 25. English, Spanish.

PMID:
30154010
11.

The prognostic value of blood pressure control delay in newly diagnosed hypertensive patients.

Martín-Fernández M, Vinyoles E, Real J, Soldevila N, Muñoz MÁ, Del-Val JL, Verdú JM, Domingo M, Mundet X.

J Hypertens. 2019 Feb;37(2):426-431. doi: 10.1097/HJH.0000000000001896.

PMID:
30063640
12.

Improved adherence to Mediterranean Diet in adults with type 1 diabetes mellitus.

Granado-Casas M, Alcubierre N, Martín M, Real J, Ramírez-Morros AM, Cuadrado M, Alonso N, Falguera M, Hernández M, Aguilera E, Lecube A, Castelblanco E, Puig-Domingo M, Mauricio D.

Eur J Nutr. 2019 Sep;58(6):2271-2279. doi: 10.1007/s00394-018-1777-z. Epub 2018 Jul 17.

13.

Health inequalities in hospitalisation and mortality in patients diagnosed with heart failure in a universal healthcare coverage system.

Garcia R, Abellana R, Real J, Del Val JL, Verdú-Rotellar JM, Muñoz MA.

J Epidemiol Community Health. 2018 Sep;72(9):845-851. doi: 10.1136/jech-2017-210146. Epub 2018 Jun 13.

PMID:
29899056
14.

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database.

Real J, Serna MC, Giner-Soriano M, Forés R, Pera G, Ribes E, Alzamora M, Marsal JR, Heras A, Morros R.

BMC Cardiovasc Disord. 2018 May 8;18(1):85. doi: 10.1186/s12872-018-0822-4.

15.

Correction: Patterns of sedentary behavior in overweight and moderately obese users of the Catalan primary-health care system.

Martínez-Ramos E, Beltran AM, Martín-Borràs C, Lasaosa-Medina L, Real J, Trujillo JM, Solà-Gonfaus M, Puigdomenech E, Castillo-Ramos E, Puig-Ribera A, Giné-Garriga M, Serra-Paya N, Rodriguez-Roca B, Gascón-Catalán A, Martín-Cantera C; SEDESTACTIV group.

PLoS One. 2018 Mar 28;13(3):e0195312. doi: 10.1371/journal.pone.0195312. eCollection 2018.

16.

Previous antibiotic exposure and antibiotic resistance of commensal Staphylococcus aureus in Spanish primary care.

Boada A, Pons-Vigués M, Real J, Grezner E, Bolíbar B, Llor C.

Eur J Gen Pract. 2018 Dec;24(1):125-130. doi: 10.1080/13814788.2018.1444748.

17.

Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.

Teixidó C, Díez O, Marsal JR, Giner-Soriano M, Pera H, Martinez M, Galindo-Ortego G, Schoenenberger JA, Real J, Cruz I, Morros R.

Pediatr Dermatol. 2018 May;35(3):336-342. doi: 10.1111/pde.13438. Epub 2018 Feb 26.

PMID:
29479727
18.

Patterns of sedentary behavior in overweight and moderately obese users of the Catalan primary-health care system.

Martínez-Ramos E, Beltran AM, Martín-Borràs C, Lasaosa-Medina L, Real J, Trujillo JM, Solà-Gonfaus M, Puigdomenech E, Castillo-Ramos E, Puig-Ribera A, Giné-Garriga M, Serra-Paya N, Rodriguez-Roca B, Gascón-Catalán A, Martín-Cantera C; SEDESTACTIV group.

PLoS One. 2018 Jan 25;13(1):e0190750. doi: 10.1371/journal.pone.0190750. eCollection 2018. Erratum in: PLoS One. 2018 Mar 28;13(3):e0195312.

19.

Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 Diabetes, and Type 2 Diabetes.

Castelblanco E, Hernández M, Castelblanco A, Gratacòs M, Esquerda A, Molló À, Ramírez-Morros A, Real J, Franch-Nadal J, Fernández-Real JM, Mauricio D.

Diabetes Care. 2018 Apr;41(4):862-868. doi: 10.2337/dc17-1662. Epub 2018 Jan 22.

PMID:
29358494
20.

Effects of a Primary Care-Based Multifactorial Intervention on Physical and Cognitive Function in Frail, Elderly Individuals: A Randomized Controlled Trial.

Romera-Liebana L, Orfila F, Segura JM, Real J, Fabra ML, Möller M, Lancho S, Ramirez A, Marti N, Cullell M, Bastida N, Martinez D, Giné M, Cendrós P, Bistuer A, Perez E, Fabregat MA, Foz G.

J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1688-1674. doi: 10.1093/gerona/glx259.

Supplemental Content

Loading ...
Support Center